MedCity News

Comprehensive Autism Diagnostic Evaluation: A Guide for Medical Professionals on Supporting Families

The Patient Intake Revolution – How AI Is Eliminating Intake Busywork and Reducing Insurance Denials

As AI has evolved to be more accurate and reliable, it's become suitable for high-stakes use cases including automating health insurance verification.

By Julian Herbert

Sponsored Post

10 Top-Rated Companies That Provide Medical Interpretation Services

The health care sector is constantly operating, so patient miscommunication can occur at any time. Find out the top-rated companies that provide medical interpretation services.

By Voyce

Consumer / Employer

7 Things Employers Should Be Doing to Fulfill Their Fiduciary Duty

Employers should review their contracts, conduct claims analyses and more to meet their fiduciary responsibility, according to one expert.

By Marissa Plescia

Latest News

Sponsored Post

Get a Snapshot of the Early Stage Life Science Startup Landscape

A webinar scheduled for Thursday May 8 at 1 pm ET sponsored by Mercury will explore how early-stage medtech and biopharma investors are looking at the market and how they're advising startups in the wake of cuts to NIH and SBIR grants.

By Stephanie Baum

Startups Health Tech,

What Does HHS’ Restructuring Mean for Interoperability In Healthcare?

Experts say the fallout from HHS’ restructuring could set public health efforts back by decades by dismantling critical infrastructure. It’s also important to note that these changes cast serious doubt on the future of interoperability, pointed out Jason Prestinario, CEO of data platform Particle Health.

By Katie Adams

Sponsored Post

Navigating The Right Steps For Your Healthcare Startup

This webinar will explore how a banking platform approach could be the resource for your company.

By Mercury and MedCity News

Startups, BioPharma

Eli Lilly Turns to Alchemab to Add Another AI-Discovered ALS Drug Prospect

Eli Lilly is licensing rights to a Phase 1-ready antibody that startup Alchemab developed for amyotrophic lateral sclerosis and other neurodegenerative disorders. Lilly’s pipeline has ALS drug candidates from previous deals with QurAlis and Verge Genomics.

By Frank Vinluan

MedCity Influencers

How Healthcare Employers Can Do More To Help Providers Manage Payer Frustration

Health insurance claims are a growing headache for providers; many say their employers could do more to help them address the daily demands of insurers

By Pat Youngblood

MedCity Influencers

A Reality Check on SDOH: Challenges We Can’t Ignore

A very small percentage of health outcomes are tied to direct healthcare activities. The non-medical factors, conditions in which people are born, grow, live, and work in, more often than not, impact health outcomes more than the clinical care they receive.

By Kristin Haluch

Sponsored Post

Eliminating Blind Spots in the Patient Journey

The webinar, scheduled for May 22, will include executives from PurpleLab and feature Genentech Principal Informatics Systems Lead Dr. Ben Freiberg. Register today!

By Stephanie Baum

Policy

What Is the Economic Impact of Medicaid Work Requirements?

Between 4.6 million and 5.2 million adults would lose Medicaid coverage in 2026 due to proposed work requirements, according to a new report.

By Marissa Plescia

BioPharma, Pharma

J&J Gene Therapy for Rare, Progressive Vision-Loss Disorder Fails Phase 3 Test

Johnson & Johnson’s gene therapy for X-linked retinal pigmentosa did not meet the main vision goal of a pivotal study. J&J secured full rights to the program from gene therapy biotech MeiraGtx in 2023.

By Frank Vinluan

MedCity Influencers

The Dementia Diagnosis Gap Is Wider Than We Think

Alzheimer’s costs American families upwards of $360 billion per year, and with our growing aging population, the disease needs to be more of a public health priority.

By Elli Kaplan

MedCity Influencers

Acuity-driven Care — Leveraging Multi-level Monitoring for Complex Needs

It's time that the healthcare industry transitioned from isolated point solutions to an integrated care model that incorporates remote monitoring and virtual care management.

By Jeff Bennett

Sponsored Post

What Do Early Stage Life Science Companies Need to Grow?

Scheduled for May 8 at 1 pm ET, the conversation will include Morgan Cheatham, head of healthcare and life sciences at Breyer Capital, Gurdane Bhutani, founder and managing partner of MBX Capital, and will be moderated by Mercury Head of Healthcare and Life Sciences Ben Kromnick.

By Stephanie Baum

MedCity Influencers

Are Therapy-Bots Really Our Best Chance At Solving Population Mental Health?

Like bandaids, AI chatbots can comfort us in times of desperation. But healing a wound takes more than a comforting bandaid.

By Helena Plater-Zyberk

Consumer / Employer, Policy

The Policy Trends the Business Group on Health Is Watching

The Business Group on Health is paying attention to Medicaid cuts, tariffs, threats to ERISA and more.

By Marissa Plescia

Hospitals’ Costs Are Soaring: 3 Stats to Know

Hospitals' costs are climbing steadily — driven by chronic underpayments from payers, growing administrative requirements and increasing labor costs, according to a new report from the American Hospital Association.

By Katie Adams

MedCity Influencers

So What’s the Deal with ICHRA?

The number of US employees offered ICHRAs continues to grow. Yet, headwinds – including competition, individual coverage market uncertainty, and complexity – may hamper the ICHRA opportunity.

By John Syme